Pharma Equity Group A/S: Financial statements 2024
CVR: 26791413
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -24,422,000 compared with DKK -24,609,000 the year before. Equity in the 2024 report amounted to DKK 48,875,000. The solvency ratio was 74.5%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -24,422,000
- Equity
- DKK 48,875,000
- Total Assets
- DKK 65,606,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | 0 | -24.4 mio. | 48.9 mio. | - |
| 2023 | 0 | 0 | -24.6 mio. | 38.9 mio. | - |
| 2022 | - | - | 3.5 mio. | 46 mio. | - |
| 2021 | - | - | 5.4 mio. | 42.6 mio. | - |
| 2020 | - | - | -32.9 mio. | 34.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 29, 2024, Martin Engell-Rossen has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2024 – September 30, 2024.
As of October 11, 2024, DMZ HOLDING ApS is registered as an owner of Pharma Equity Group A/S with an ownership share of 10%.
Pharma Equity Group A/S has published its interim report for the period January 1, 2024 – June 30, 2024.
As of July 11, 2024, FINANSMANAGEMENT ApS is registered as an owner of Pharma Equity Group A/S with an ownership share of 15%.
Pharma Equity Group A/S has published its interim report for the period January 1, 2024 – March 31, 2024.
Pharma Equity Group A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -24,609,000.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.